Medicine Description averofage
averofage to lower blood sugar level is a medication that combines metformin and pioglitazone to enhance glycemic control in patients with type 2 diabetes. Metformin primarily functions by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues, thus facilitating glucose uptake by cells. Pioglitazone, on the other hand, is a thiazolidinedione that acts by activating peroxisome proliferator-activated receptors (PPAR-gamma), which play a crucial role in regulating glucose and lipid metabolism. This dual action not only helps in lowering blood glucose levels but also contributes to improved lipid profiles and potential weight management.
Indications and Uses of averofage to lower blood sugar level
- Management of type 2 diabetes mellitus
- Improvement of glycemic control in conjunction with diet and exercise
- Used in patients who have insufficient glycemic control with metformin alone
- May be prescribed as part of a comprehensive diabetes management plan
Side Effects of averofage to lower blood sugar level
- Hypoglycemia
- Weight gain
- Edema
- Gastrointestinal disturbances (nausea, diarrhea)
- Liver enzyme elevation
- Potential for heart failure exacerbation
Storage and Handling
Store averofage at room temperature, away from direct sunlight, moisture, and heat. Keep it in its original container and out of reach of children.
Patient Advice and Precautions
Patients should regularly monitor their blood glucose levels and adhere to prescribed lifestyle modifications, including diet and exercise. It is crucial to inform healthcare providers about any existing medical conditions or medications to avoid potential interactions. Regular check-ups should be scheduled to monitor liver function and assess the effectiveness of the treatment.